HCCI's work on insulin pricing was cited in a Boston Globe article.
From the article:
"Following similar efforts in Colorado and Minnesota, the Senate bill also targets the costs of insulin, a commonly used drug that has become increasingly unaffordable for many patients.
On average, the price of all types of insulin roughly doubled between 2012 and 2016, according to the Washington-based Health Care Cost Institute."
Senate leaders to offer antidote for high drug costs - The Boston Globe